微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.27% | -20.63% | -47.95% | 79/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 2.44% | -73.65% | -50.2% | 80/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 4.9% | -35.36% | 60.13% | 64/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 3.06% | -23.88% | 91.25% | 62/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 1.6% | -14.89% | -82.72% | 68/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 9.26% | 132.08% | 22.16% | 34/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 7.58% | 106.54% | 88.56% | 43/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 4.02% | 162.75% | 113.83% | 51/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 1.88% | 189.23% | -52.88% | 62/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 3.99% | -52.78% | 8.72% | 72/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 3.67% | -57.28% | 139.87% | 84/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 1.53% | -73.62% | 135.38% | 92/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 0.65% | -76.28% | -92.31% | 104/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 8.45% | -38.59% | -1.63% | 51/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 8.59% | 2% | 48.1% | 39/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 5.8% | -11.31% | 111.68% | 37/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 2.74% | 2% | -80.09% | 43/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 13.76% | -35.61% | 110.4% | 25/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-06-30 | 6.54% | 2% | -69.4% | 35/157 | 2.99% | ST人福 | 6.82% | 行业排名> |
| 2020-12-31 | 21.37% | 435.59% | 435.59% | 16/157 | 3.8% | 小方制药 | 71.99% | 行业排名> |
| 2019-12-31 | 3.99% | 128.08% | 128.08% | 94/157 | 2.57% | 汇宇制药 | 39.25% | 行业排名> |
| 2018-12-31 | -14.21% | 2% | 2% | 126/157 | 7.16% | 汇宇制药 | 28.14% | 行业排名> |